EDP-305
1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea
Molecular Identity
EDP-305
1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea
PubChem CID: 121428882
2D Structure
Properties
C36H58N2O5S
Molecular Formula
630.90
Molecular Weight
g/mol
630.4066
Exact Mass
Da
8.2
XLogP
Above Lipinski threshold
124
TPSA
Good oral absorption (< 140 A²)
4
H-Bond Donors
5
H-Bond Acceptors
1120
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
EDP-3051933507-63-17716RH2FJTEDP305RefChem:920839orb1744190CHEMBL5841645SCHEMBL17860330US10208081, Example 3BDBM350697DTXSID601359523EDP-305?US10208081, Example 77US10208081, Example 127MS-30857
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to EDP-305
Loading drug network...